- Report
- January 2025
- 175 Pages
Global
From €3997EUR$4,490USD£3,453GBP
- Report
- October 2022
- 227 Pages
Global
From €3205EUR$3,600USD£2,768GBP
Bioconvergence is a term used to describe the intersection of biotechnology and other fields, such as information technology, nanotechnology, and materials science. It is a rapidly growing market, driven by the need to develop innovative solutions to complex problems. Bioconvergence is focused on the development of new technologies and products that combine the strengths of multiple disciplines to create a more efficient and effective solution.
Bioconvergence has been used to develop a wide range of products, from medical devices to agricultural products. It has also been used to develop new treatments for diseases, such as cancer and Alzheimer's. Additionally, bioconvergence has been used to create new materials and processes for manufacturing, as well as to develop new methods of data analysis.
Some of the companies in the bioconvergence market include Illumina, Thermo Fisher Scientific, Merck, and Roche. Other companies include Agilent Technologies, Cellectis, and Genentech. Show Less Read more